You have 9 free searches left this month | for more free features.

Biphenotypic/Undifferentiated/Prolymphocytic Leukemias

Showing 1 - 25 of 295

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

Recruiting
  • Acute Leukemia
  • +27 more
  • HSCT with TBI Regimen
  • HSCT with Non-TBI Regimen
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Apr 12, 2022

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)

Recruiting
  • Acute Leukemia
  • +24 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 4, 2021

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Peripheral Blood Stem Cell Transplant
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Mar 27, 2023

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total

Active, not recruiting
  • Acute Myeloid Leukemia
  • +17 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023

Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)

Recruiting
  • Hematologic Malignancies
  • Haplo HCT <55 years old
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 25, 2023

Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies Trial in Minneapolis (Infusion of Treg)

Terminated
  • Acute Lymphoblastic Leukemia
  • +17 more
  • Infusion of Treg
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Sep 8, 2020

Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)

Active, not recruiting
  • Sarcoma, Soft Tissue
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
Oct 29, 2023

CLL, SLL, HCL Trial in Dresden

Recruiting
  • CLL
  • +7 more
    • Dresden, Sachsen, Germany
      BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
    Apr 29, 2022

    Thyroid Cancer, Anaplastic Thyroid Cancer, Undifferentiated Thyroid Cancer Trial in Stanford (Abemaciclib)

    Active, not recruiting
    • Thyroid Cancer
    • +2 more
    • Stanford, California
      Stanford University
    Nov 8, 2022

    Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

    Not yet recruiting
    • Refractory Leukemia
    • +4 more
    • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
    • Dendritic Cell Vaccine
    • Miami, Florida
      University of Miami
    Jan 23, 2023

    Undifferentiated Pleomorphic Sarcoma Trial in Iowa City (Palbociclib, Pembrolizumab)

    Not yet recruiting
    • Undifferentiated Pleomorphic Sarcoma
    • Iowa City, Iowa
      University of Iowa Hospitals & Clinics
    Nov 1, 2023

    Transient Loss of Consciousness and Suspected Syncope in

    Recruiting
    • Syncope
    • Data collection
    • Durres, Albania
    • +56 more
    Oct 4, 2022

    Agitation, Schizophrenia, Schizoaffective Disorder Trial (Sublingual film containing dexmedetomidine (BXCL501))

    Not yet recruiting
    • Agitation
    • +4 more
    • Sublingual film containing dexmedetomidine (BXCL501)
    • (no location specified)
    Jul 26, 2023

    Sinonasal Undifferentiated Carcinoma Trial in Pavia (Pembrolizumab)

    Not yet recruiting
    • Sinonasal Undifferentiated Carcinoma
    • Pavia, Lombardia, Italy
      Istituti Clinici Scientifici Maugeri
    Jun 21, 2023

    Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati

    Recruiting
    • Relapsed/Refractory Leukemias
    • +4 more
    • Kansas City, Missouri
    • +1 more
    Jul 18, 2022

    Study and Monitoring of Early Undifferentiated Arthritis

    Active, not recruiting
    • Early Rheumatoid Arthritis or Early Undiffentiated Arthritis
      • (no location specified)
      Oct 25, 2022

      Utilizing MRI for Earlier Diagnosis of Rheumatoid Arthritis

      Active, not recruiting
      • Rheumatoid Arthritis
      • MRI
      • Rochester, Minnesota
        Mayo Clinic
      Jan 5, 2023

      Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial (drug, radiation, procedure)

      Not yet recruiting
      • Acute Leukemia
      • +4 more
      • (no location specified)
      Oct 18, 2022

      Undifferentiated Pleomorphic Sarcoma Trial in San Francisco (ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound

      Recruiting
      • Undifferentiated Pleomorphic Sarcoma
      • ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS)
      • San Francisco, California
        University of California, San Francisco
      Feb 28, 2022

      Development of B-cell Leukemias and Lymphomas in Children of

      Not yet recruiting
      • B Cell Leukemia
      • Lymphoma
      • SNP analysis of the DNA
      • (no location specified)
      Oct 26, 2021

      Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies Trial in Philadelphia (RIC: Distal Campath, RIC:Intermediate

      Recruiting
      • Non Malignant Diseases
      • +2 more
      • RIC: Distal Campath
      • +2 more
      • Philadelphia, Pennsylvania
        The Children's Hospital of Philadelphia
      Mar 8, 2022

      The Pediatric Acute Leukemia Screening Trial - A Study to Test

      Recruiting
      • Recurrent Acute Lymphoblastic Leukemia
      • +7 more
      • Biospecimen Collection
      • Birmingham, Alabama
      • +144 more
      Jan 30, 2023

      Dedifferentiated Liposarcoma, Recurrent Dedifferentiated Liposarcoma, Recurrent Undifferentiated Pleomorphic Sarcoma Trial in

      Active, not recruiting
      • Dedifferentiated Liposarcoma
      • +5 more
      • Ipilimumab
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 25, 2022